Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8515772rdf:typepubmed:Citationlld:pubmed
pubmed-article:8515772lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:8515772lifeskim:mentionsumls-concept:C0014323lld:lifeskim
pubmed-article:8515772lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:8515772lifeskim:mentionsumls-concept:C0450254lld:lifeskim
pubmed-article:8515772pubmed:issue1lld:pubmed
pubmed-article:8515772pubmed:dateCreated1993-7-20lld:pubmed
pubmed-article:8515772pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515772pubmed:abstractTextSimilar to the findings obtained with pathogenic Entamoeba histolytica, nonpathogenic isolates were found to kill mammalian cells in vitro, and cell extract caused pore formation in liposome membranes. A pore-forming peptide termed APnp was isolated from a nonpathogenic isolate using the schedule developed for the purification of APp or amoebapore, the homologous peptide of the pathogenic isolate HM-1:IMSS. Compared to APp, the specific activity of APnp in pore formation was 60% lower. cDNA sequencing indicated 95% identity of the primary structures of APnp and APp, and secondary structure predictions revealed a high degree of similarity. Notably, a glutamic acid residue at position 2 of APp is in APnp replaced by proline, which shortens one of the two amphipathic alpha-helices considered crucial for the pore-forming function. This structural divergence of the two peptides might explain the difference in their pore-forming activities.lld:pubmed
pubmed-article:8515772pubmed:languageenglld:pubmed
pubmed-article:8515772pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515772pubmed:citationSubsetIMlld:pubmed
pubmed-article:8515772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515772pubmed:statusMEDLINElld:pubmed
pubmed-article:8515772pubmed:monthMaylld:pubmed
pubmed-article:8515772pubmed:issn0166-6851lld:pubmed
pubmed-article:8515772pubmed:authorpubmed-author:BahnIIlld:pubmed
pubmed-article:8515772pubmed:authorpubmed-author:LeippeMMlld:pubmed
pubmed-article:8515772pubmed:authorpubmed-author:TannichEElld:pubmed
pubmed-article:8515772pubmed:authorpubmed-author:HorstmannR...lld:pubmed
pubmed-article:8515772pubmed:issnTypePrintlld:pubmed
pubmed-article:8515772pubmed:volume59lld:pubmed
pubmed-article:8515772pubmed:ownerNLMlld:pubmed
pubmed-article:8515772pubmed:authorsCompleteYlld:pubmed
pubmed-article:8515772pubmed:pagination101-9lld:pubmed
pubmed-article:8515772pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:meshHeadingpubmed-meshheading:8515772-...lld:pubmed
pubmed-article:8515772pubmed:year1993lld:pubmed
pubmed-article:8515772pubmed:articleTitleComparison of pore-forming peptides from pathogenic and nonpathogenic Entamoeba histolytica.lld:pubmed
pubmed-article:8515772pubmed:affiliationBernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.lld:pubmed
pubmed-article:8515772pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8515772pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8515772pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8515772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8515772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8515772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8515772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8515772lld:pubmed